Skip to main content

Articles

Page 21 of 85

  1. Acute kidney injury (AKI) causes abrupt deterioration in kidney function that disrupts metabolic, electrolyte and fluid homeostasis. Although the prevalence of AKI is steadily increasing, no definitive treatme...

    Authors: Ramanaiah Mamillapalli, SiHyun Cho, Levent Mutlu and Hugh S. Taylor
    Citation: Stem Cell Research & Therapy 2022 13:107
  2. The balance between osteogenesis and adipogenesis of mesenchymal stem cells (MSCs) is critical to skeletal development and diseases. As a research hotspot, circular RNAs (circRNAs) have expanded our understand...

    Authors: Hai-Bo Huang, Hai-Tao Luo, Na-Na Wei, Miao-Ling Liu, Fei He, Wei Yang, Jun Dong, Xiao-Fei Yang and Fu-Rong Li
    Citation: Stem Cell Research & Therapy 2022 13:106
  3. The short-term safety and efficacy of stromal vascular fraction (SVF) in treating knee osteoarthritis (KOA) have been extensively studied but the mid-term and long-term prognoses remain unknown.

    Authors: Shengyang Zhang, Huihui Xu, Bangjian He, Mengqiang Fan, Miaomiao Xiao, Jingjing Zhang, Di Chen, Peijian Tong and Qiang Mao
    Citation: Stem Cell Research & Therapy 2022 13:105
  4. The liver plays an important role in various metabolic processes, including protein synthesis, lipid and drug metabolisms and detoxifications. Primary culture of hepatocytes is used for the understanding of li...

    Authors: Saeko Akiyama, Noriaki Saku, Shoko Miyata, Kenta Ite, Masashi Toyoda, Tohru Kimura, Masahiko Kuroda, Atsuko Nakazawa, Mureo Kasahara, Hidenori Nonaka, Akihide Kamiya, Tohru Kiyono, Tohru Kobayshi, Yasufumi Murakami and Akihiro Umezawa
    Citation: Stem Cell Research & Therapy 2022 13:104
  5. To determine the effects of integrase inhibitor (INSTI) in comparison with non-INSTI-based regimens such as non-nucleoside reverse transcriptase inhibitors (NNRTIs)-based regimens on cardiovascular disease (CV...

    Authors: Adrian Farid Elzarki, Seshagiri Rao Nandula, Hassan Awal, Gary L. Simon and Sabyasachi Sen
    Citation: Stem Cell Research & Therapy 2022 13:103
  6. Thalassemia is a genetic blood disorder characterized by decreased hemoglobin production. Severe anemia can damage organs and severe threat to life safety. Allogeneic transplantation of bone marrow-derived hem...

    Authors: Lingli Li, Hongyan Yi, Zheng Liu, Ping Long, Tao Pan, Yuanhua Huang, Yongsheng Li, Qi Li and Yanlin Ma
    Citation: Stem Cell Research & Therapy 2022 13:102
  7. The autoimmune diseases are associated with the host immune system, chronic inflammation, and immune reaction against self-antigens, which leads to the injury and failure of several tissues. The onset of autoi...

    Authors: Saade Abdalkareem Jasim, Alexei Valerievich Yumashev, Walid Kamal Abdelbasset, Ria Margiana, Alexander Markov, Wanich Suksatan, Benjamin Pineda, Lakshmi Thangavelu and Seyed Hossein Ahmadi
    Citation: Stem Cell Research & Therapy 2022 13:101
  8. Autoimmune uveitis is a sight-threatening intraocular inflammation mainly caused by immune dysregulation. The development of safe and effective therapeutic approaches is urgently needed. Small extracellular ve...

    Authors: Yongtao Li, Xinjun Ren, Zhihui Zhang, Yanan Duan, Huan Li, Shuang Chen, Hui Shao, Xiaorong Li and Xiaomin Zhang
    Citation: Stem Cell Research & Therapy 2022 13:100
  9. Mesenchymal stem cells (MSC)-based tissue engineered breast represent the visible future for breast reconstruction after mastectomy. However, autologous MSCs might not be appropriate for the large graft constr...

    Authors: Mian Wu, Lifeng Chen, Yuhan Qi, Hai Ci, Shan Mou, Jie Yang, Qiaoyu Yuan, Weiqi Yao, Zhenxing Wang and Jiaming Sun
    Citation: Stem Cell Research & Therapy 2022 13:99
  10. Mesenchymal stem cells (MSCs) have therapeutic potential for atopic dermatitis (AD) owing to their immunoregulatory effects. However, the underlying mechanisms associated with the therapeutic efficacy of MSCs ...

    Authors: Jingyan Guan, Yibao Li, Feng Lu and Jingwei Feng
    Citation: Stem Cell Research & Therapy 2022 13:98
  11. Natural killer cells (NK cells) are innate immune cells that are activated to fight tumor cells and virus-infected cells. NK cells also play an important role in the graft versus leukemia response. However, th...

    Authors: Batol Abbasi, Karim Shamsasenjan, Majid Ahmadi, Seyedeh Ameneh Beheshti and Mahshid Saleh
    Citation: Stem Cell Research & Therapy 2022 13:97
  12. Cell-free Mesenchymal stromal cells (MSCs) have been considered due to their capacity to modulate the immune system and suppress cytokine storms caused by SARS-CoV-2. This prospective randomized double-blind p...

    Authors: Mina Fathi-Kazerooni, Samrand Fattah-Ghazi, Maryam Darzi, Jalil Makarem, Reza Nasiri, Faeze Salahshour, Seyed Ali Dehghan-Manshadi and Somaieh Kazemnejad
    Citation: Stem Cell Research & Therapy 2022 13:96
  13. Vascular abnormalities in the ovary cause infertility accompanied by ovarian insufficiency due to a microenvironment of barren ovarian tissues. Placenta-derived mesenchymal stem cells (PD-MSCs, Naïve) treatmen...

    Authors: Hyeri Park, Jin Seok, Jun Hyeong You, Jae Yeon Kim, Ja-Yun Lim and Gi Jin Kim
    Citation: Stem Cell Research & Therapy 2022 13:95
  14. Acetaminophen (APAP) overdose is a major cause of the morbidity of acute liver failure. The current clinically approved treatment for APAP poisoning, N-acetylcysteine (NAC), has a limited therapeutic window, and ...

    Authors: Ping Wang, Yan Cui, Jing Wang, Donghua Liu, Yue Tian, Kai Liu, Xue Wang, Lin Liu, Yu He, Yufeng Pei, Li Li, Liying Sun, Zhijun Zhu, Dehua Chang, Jidong Jia and Hong You
    Citation: Stem Cell Research & Therapy 2022 13:94
  15. Graft-versus-host disease (GVHD) is a common fatal complication of hematopoietic stem cell transplantation (HSCT), where steroids are used as a treatment option. However, there are currently no second-line tre...

    Authors: Ying Li, Jie Hao, Zheng Hu, Yong-Guang Yang, Qi Zhou, Liguang Sun and Jun Wu
    Citation: Stem Cell Research & Therapy 2022 13:93
  16. Treatments based on stem cell-derived small extracellular vesicles (sEVs) have been explored as an alternative to stem cell transplantation-based therapies in periodontal regeneration. Dental follicle stem cel...

    Authors: Liya Ma, Nanquan Rao, Hui Jiang, Yuzhe Dai, Songtao Yang, Hefeng Yang and Jiangtian Hu
    Citation: Stem Cell Research & Therapy 2022 13:92
  17. Hyperglycemia contributes to cardiovascular complications in patients with type 2 diabetes. We confirmed that high glucose (HG) induces endothelial dysfunction and cerebral ischemic injury is enlarged in diabe...

    Authors: Manasi Suchit Halurkar, Jinju Wang, Shuzhen Chen and Ji Chen Bihl
    Citation: Stem Cell Research & Therapy 2022 13:91
  18. The transplantation of bone marrow-derived mesenchymal stem cells (BMMSCs) alleviates neuropathology and improves cognitive deficits in animal models with Alzheimer’s disease. However, the underlying mechanism...

    Authors: Chuan Qin, Lin Bai, Yongning Li and Kewei Wang
    Citation: Stem Cell Research & Therapy 2022 13:90
  19. Anti-angiogenic therapy has been shown to be a promising strategy for anti-tumor treatment. Increasing evidence indicates that tumor angiogenesis is affected by exosomes that are secreted by mesenchymal stem c...

    Authors: Panpan Liu, Qun Zhang, Jun Mi, Shuangshuang Wang, Qiuping Xu, Dexuan Zhuang, Wenqian Chen, Chang Liu, Liwei Zhang, Jing Guo and Xunwei Wu
    Citation: Stem Cell Research & Therapy 2022 13:89
  20. The present study is a phase I/IIa non-randomized, open-label study to evaluate safety and efficacy of a single, intravenous infusion of autologous, adipose-derived mesenchymal stem cells (adMSCs) over a perio...

    Authors: Ridhima Vij, Kevin A. Stebbings, Hosu Kim, Hyeonggeun Park and Donna Chang
    Citation: Stem Cell Research & Therapy 2022 13:88
  21. Stroke is the second leading cause globally that leads to severe disability and death. Stem cell therapy has been developed over the recent years to treat stroke and diminish the mortality and disability rate ...

    Authors: Huidong Jia, Jia He, Lan Zhao, Chia-Chen Hsu, Xiaofeng Zhao, Yuzheng Du, Lin Han, Zhanfeng Cui, Xuemin Shi and Hua Ye
    Citation: Stem Cell Research & Therapy 2022 13:87
  22. Cell-free therapy has been inspired as a promising approach to overcome the limitations of traditional stem cell therapy. However, the therapeutic effect between extracellular vesicles and conditioned medium w...

    Authors: Chuan He, Minjia Dai, Xiaojie Zhou, Jie Long, Weidong Tian and Mei Yu
    Citation: Stem Cell Research & Therapy 2022 13:86
  23. Intrauterine adhesion and cesarean scar diverticulum are the main complications of poor healing after uterine injury. Human umbilical cord MSCs transplantation has been regarded as the most potential treatment...

    Authors: Jingrui Huang, Qi Li, Xiaohua Yuan, Qiaoshu Liu, Weishe Zhang and Ping Li
    Citation: Stem Cell Research & Therapy 2022 13:85
  24. Abdominal aortic aneurysm (AAA) is life-threatening, surgical treatment is currently the only clinically available intervention for the disease. Mesenchymal stem cells (MSCs) have presented eligible immunomodu...

    Authors: Xintong Li, Hao Wen, Junyuan Lv, Boyang Luan, Jinze Meng, Shiqiang Gong, Jie Wen and Shijie Xin
    Citation: Stem Cell Research & Therapy 2022 13:81
  25. Tendon derived stem cells (TDSCs) have proven to be effective in tendon repair by secreting paracrine factors, which modulate the function of resident cells and inflammatory process. Exosomes, which are secret...

    Authors: Kai Song, Tao Jiang, Pin Pan, Yao Yao and Qing Jiang
    Citation: Stem Cell Research & Therapy 2022 13:80
  26. Chemotherapy can induce premature ovarian insufficiency (POI). POI causes multiple sequelae and is currently incurable. As shown in our previous studies, systemically transplanted human amnion-derived mesenchy...

    Authors: Li Ling, Jiying Hou, Dandan Liu, Dongyuan Tang, Yanqin Zhang, Qianru Zeng, Heng Pan and Ling Fan
    Citation: Stem Cell Research & Therapy 2022 13:79
  27. Commitment of mouse dental papilla cells (mDPCs) to the odontoblast lineage is critical for dentin formation, and this biological process is regulated by a complex transcription factor network. The transcripti...

    Authors: Zhuo Huang, Ruihuan Yang, Ruyi Li, Yining Zuo, Fan Gu, Miao He and Zhuan Bian
    Citation: Stem Cell Research & Therapy 2022 13:78
  28. Controlling the adipo-osteogenic lineage commitment of bone marrow mesenchymal stem cell (BMSC) in favor of osteogenesis is considered a promising approach for bone regeneration and repair. Accumulating eviden...

    Authors: Boer Li, Yu Shi, Mengyu Liu, Fanzi Wu, Xuchen Hu, Fanyuan Yu, Chenglin Wang and Ling Ye
    Citation: Stem Cell Research & Therapy 2022 13:77
  29. Hemolysis occurs in many injury settings and can trigger disease processes. In the kidney, extracellular hemoglobin can induce damage via several mechanisms. These include oxidative stress, mitochondrial dysfu...

    Authors: Aneta Przepiorski, Thitinee Vanichapol, Eugenel B. Espiritu, Amanda E. Crunk, Emily Parasky, Michael D. McDaniels, Dave R. Emlet, Ryan Salisbury, Cassandra L. Happ, Lawrence A. Vernetti, Matthew L. MacDonald, John A. Kellum, Thomas R. Kleyman, Catherine J. Baty, Alan J. Davidson and Neil A. Hukriede
    Citation: Stem Cell Research & Therapy 2022 13:76
  30. Cell therapy, particularly mesenchymal stem/stromal (MSC) therapy, has been investigated for a wide variety of disease indications, particularly those with inflammatory pathologies. However, recently it has be...

    Authors: Senthilkumar Alagesan, Jack Brady, Declan Byrnes, Juan Fandiño, Claire Masterson, Sean McCarthy, John Laffey and Daniel O’Toole
    Citation: Stem Cell Research & Therapy 2022 13:75
  31. Reproduction is a key event in life guaranteeing the propagation and evolution of a species. Infertility caused by abnormal germ cell development is a topic of extensive concern. Herein, in vitro germline spec...

    Authors: Chunmeng Yao, Ruqiang Yao, Haining Luo and Ling Shuai
    Citation: Stem Cell Research & Therapy 2022 13:74
  32. Mesenchymal stem cell (MSC)-based tissue engineering plays a major role in regenerative medicine. However, the efficiency of MSC transplantation and survival of engrafted stem cells remain challenging. Melaton...

    Authors: Ya-Hui Chan, Kuo-Ning Ho, Yu-Chieh Lee, Meng-Jung Chou, Wei-Zhen Lew, Haw-Ming Huang, Pin-Chuang Lai and Sheng-Wei Feng
    Citation: Stem Cell Research & Therapy 2022 13:73
  33. Selected renal cells (SRC) are in Phase II clinical trials as a kidney-sourced, autologous, tubular epithelial cell-enriched cell-based therapy for chronic kidney disease (CKD). In preclinical studies with rod...

    Authors: Wei Sha, Timothy Bertram, Deepak Jain, Cory Brouwer and Joydeep Basu
    Citation: Stem Cell Research & Therapy 2022 13:72
  34. Pulmonary fibrosis is a devastating disease that eventually leads to death and respiratory failure. Despite the wide range of drugs, including corticosteroids, endothelin antagonist, and pirfenidone, there is ...

    Authors: Mahshid Saleh, Seyedeh Zahra Fotook Kiaei and Maria Kavianpour
    Citation: Stem Cell Research & Therapy 2022 13:71
  35. Intervertebral disc degeneration (IDD) is a common disease that increases with age, and its occurrence is stressful both psychologically and financially. Stem cell therapy for IDD is emerging. For this therapy...

    Authors: Wentao Zhang, Tianze Sun, Ying Li, Ming Yang, Yantao Zhao, Jing Liu and Zhonghai Li
    Citation: Stem Cell Research & Therapy 2022 13:70
  36. Over 400 million people worldwide are living with a rare disease. Next Generation Sequencing (NGS) identifies potential disease causative genetic variants. However, many are identified as variants of uncertain...

    Authors: Vanessa S. Fear, Catherine A. Forbes, Denise Anderson, Sebastian Rauschert, Genevieve Syn, Nicole Shaw, Sarra Jamieson, Michelle Ward, Gareth Baynam and Timo Lassmann
    Citation: Stem Cell Research & Therapy 2022 13:69
  37. Underactive bladder (UAB) is a common clinical problem but related research is rarely explored. As there are currently no effective therapies, the administration of adipose stromal vascular fraction (ad-SVF) p...

    Authors: Jingyu Liu, Liuhua Zhou, Feng Zhao, Changcheng Zhou, Tianli Yang, Zhongle Xu, Xinning Wang, Luwei Xu, Zheng Xu, Yuzheng Ge, Ran Wu and Ruipeng Jia
    Citation: Stem Cell Research & Therapy 2022 13:68
  38. Perianal fistulas in Crohn's disease are frequent and disabling, with a major impact on patients' quality of life. Cell-based therapy using mesenchymal stem cells represents new hope for these patients, but lo...

    Authors: Lucas Guillo, Fanny Grimaud, Fanny Houser, Caroline Prost, Elisabeth Jouve, Cécile Philandrianos, Maxime Abellan, Julie Veran, Carine Visee, Laura Beyer-Berjot, Ariadne Desjeux, Françoise Dignat-George, Marc Leone, Jean-Charles Grimaud, Florence Sabatier, Mélanie Serrero…
    Citation: Stem Cell Research & Therapy 2022 13:67
  39. Thin endometrium is a primary cause of defective endometrial receptivity, resulting in infertility or recurrent miscarriage. Much effort has been devoted toward regenerating thin endometrium by stem cell-based...

    Authors: Yifeng Lin, Shunni Dong, Xiaohang Ye, Juan Liu, Jiaqun Li, Yanye Zhang, Mixue Tu, Siwen Wang, Yanyun Ying, Ruixue Chen, Feixia Wang, Feida Ni, Jianpeng Chen, Binyang Du and Dan Zhang
    Citation: Stem Cell Research & Therapy 2022 13:66
  40. Authors: Yulin He, Xingrong Guo, Tingyu Lan, Jianbo Xia, Jinsong Wang, Bei Li, Chunyan Peng, Yue Chen, Xiang Hu and Zhongji Meng
    Citation: Stem Cell Research & Therapy 2022 13:65

    The original article was published in Stem Cell Research & Therapy 2021 12:396

  41. Recent advances in single-cell RNA sequencing (scRNA-seq) and epithelium lineage labeling have yielded identification of multiple abnormal epithelial progenitor populations during alveolar type 2 (ATII) cell d...

    Authors: Ting Xie, Heather Lynn, William C. Parks, Barry Stripp, Peter Chen, Dianhua Jiang and Paul W. Noble
    Citation: Stem Cell Research & Therapy 2022 13:64
  42. Bone marrow-derived mesenchymal stem cells (MSCs), which possess immunomodulatory characteristic, are promising candidates for the treatment of acute myocardial infarction (AMI). However, the low retention and...

    Authors: Yuyan Xiong, Ruijie Tang, Junyan Xu, Wenyang Jiang, Zhaoting Gong, Lili Zhang, Xiaosong Li, Yu Ning, Peisen Huang, Jun Xu, Guihao Chen, Chen Jin, Xiangdong Li, Haiyan Qian and Yuejin Yang
    Citation: Stem Cell Research & Therapy 2022 13:63
  43. Structural regeneration of amputated appendages by blastema-mediated, epimorphic regeneration is a process whose mechanisms are beginning to be employed for inducing regeneration. While epimorphic regeneration...

    Authors: Connor P. Dolan, Tae-Jung Yang, Katherine Zimmel, Felisha Imholt, Osama Qureshi, Alyssa Falck, Joshua Gregory, Macie Mayes, Kayla Ritchie, Hannah Koester, Benjamin Daniel, Mingquan Yan, Ling Yu, Larry J. Suva, Dana Gaddy, Lindsay A. Dawson…
    Citation: Stem Cell Research & Therapy 2022 13:62
  44. Coronavirus disease 2019 (COVID-19) is a highly infectious epidemic disease that has seriously affected human health worldwide. To date, however, there is still no definitive drug for the treatment of COVID-19...

    Authors: Kun Lu, Shi-tao Geng, Shikai Tang, Hua Yang, Wei Xiong, Fang Xu, Qijun Yuan, Xian Xiao, Renqiang Huang, Haihui Liang, Zhipeng Chen, Chuanyun Qian, Yang Li and Songqing Wang
    Citation: Stem Cell Research & Therapy 2022 13:61
  45. True identity and specific set of markers to enrich endometrial stem cells still remains elusive. Present study was undertaken to further substantiate that very small embryonic-like stem cells (VSELs) are the ...

    Authors: Pushpa Singh, Siddhanath Metkari and Deepa Bhartiya
    Citation: Stem Cell Research & Therapy 2022 13:60
  46. Cholestatic liver injury can lead to serious symptoms and prognoses in the clinic. Currently, an effective medical treatment is not available for cholestatic liver injury. Human menstrual blood-derived stem ce...

    Authors: Ya Yang, Yanfei Chen, Yalei Zhao, Feiyang Ji, Lingjian Zhang, Shima Tang, Sainan Zhang, Qingqing Hu, Zuhong Li, Fen Zhang, Qian Li and Lanjuan Li
    Citation: Stem Cell Research & Therapy 2022 13:57
  47. Ex vivo production of induced megakaryocytes (MKs) and platelets from stem cells is an alternative approach for supplying transfusible platelets. However, it is difficult to generate large numbers of MKs and p...

    Authors: Jianan Jiang, Jinhua Qin, Jisheng Li, Xiaosong Lin, Bowen Zhang, Zeng Fan, Lijuan He, Quan Zeng, Wen Yue, Min Zheng, Xuetao Pei and Yanhua Li
    Citation: Stem Cell Research & Therapy 2022 13:54

Annual Journal Metrics

  • 2022 Citation Impact
    7.5 - 2-year Impact Factor
    8.0 - 5-year Impact Factor
    1.440 - SNIP (Source Normalized Impact per Paper)
    1.498 - SJR (SCImago Journal Rank)

    2023 Speed
    33 days submission to first editorial decision for all manuscripts (Median)
    211 days submission to accept (Median)

    2023 Usage 
    3,320,811 downloads
    1,402 Altmetric mentions